Friday, 25 August 2017

FDA clears Novo Nordisk's diabetes drug to treat heart diseases

(Reuters) - Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved its diabetes drug as a treatment to reduce the risk of three major cardiovascular diseases.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)